Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net earnings	$ 286,160	$ 268,642
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	246,979	246,648
Stock-based compensation expense	23,330	22,435
Change in estimated sales allowances	(26,069)	180,391
Deferred income tax benefit	(16,659)	(57,076)
Other non-cash items	54,996	126,517
Litigation settlements, net	8,733	(10,033)
Changes in operating assets and liabilities:
Accounts receivable	(107,598)	(288,011)
Inventories	(169,201)	(109,639)
Trade accounts payable	81,262	(8,975)
Income taxes	(42,542)	(32,837)
Deferred revenue	(134)	(14,645)
Other operating assets and liabilities, net	(65,216)	(127,824)
Net cash provided by operating activities	274,041	195,593
Cash flows from investing activities:
Capital expenditures	(125,657)	(98,918)
Change in restricted cash	(50,550)	7,555
Cash paid for acquisitions, net	(37,100)	0
Purchase of marketable securities	(9,481)	(7,957)
Proceeds from sale of marketable securities	5,275	6,568
Other items, net	(13,641)	(73,131)
Net cash used in investing activities	(231,154)	(165,883)
Cash flows from financing activities:
Payment of financing fees	(18,496)	(1,252)
Purchase of common stock	(500,000)	(499,953)
Change in short-term borrowings, net	113,933	283,108
Proceeds from issuance of long-term debt	1,758,267	835,000
Payment of long-term debt	(1,517,266)	(732,549)
Proceeds from exercise of stock options	38,659	27,676
Other items, net	17,174	5,587
Net cash used in financing activities	(107,729)	(82,383)
Effect on cash of changes in exchange rates	(7,748)	(8,052)
Net decrease in cash and cash equivalents	(72,590)	(60,725)
Cash and cash equivalents — beginning of period	349,969	375,056
Cash and cash equivalents — end of period	$ 277,379	$ 314,331